The macrolides inhibit bacterial ribosomal protein synthesis, interfering with protein translocation by binding the 50S subunit. The macrolides are bacteriostatic but, depending on the concentration and micro-organism, can have bacteriocidal action.

Patients should be advised to complete the prescribed course of antibiotic therapy.
The macrolides are primarily administered orally, they diffuse well into all tissues but do not cross the blood brain barrier and penetration into the synovial fluid is poor, so these drugs are not useful in CNS or joint infections.
Their effects on cytochrome p450 enzyme can affect other drugs.
The major route of elimination is in the bile.